Your session is about to expire
← Back to Search
Local Anesthetic
bupivacaine for Labor Pain
N/A
Waitlist Available
Research Sponsored by Mark Kosanovich
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
adult pregnant women to age 45 with scheduled cesarean sections at Mercy Hospital and Medical Center
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up post 120 minutes after arrival in the recovery room
Awards & highlights
Summary
This research will explore the question of whether preincisional skin infiltration with bupivacaine 0.25% decreases postoperative pain after Cesarean delivery.
Eligible Conditions
- Labor Pain
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 120 minutes after arrival in the recovery room
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~120 minutes after arrival in the recovery room
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Final score on the visual analogous scale
Secondary study objectives
Analgesics
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: bupivacaineExperimental Treatment1 Intervention
Intervention
Group II: PlaceboPlacebo Group1 Intervention
Control
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Bupivacaine
FDA approved
Find a Location
Who is running the clinical trial?
Mark KosanovichLead Sponsor
Rohitkumar Vasa, MDStudy ChairIRB Chair
Share this study with friends
Copy Link
Messenger